Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) has issued an announcement.
Predict S.p.A. has approved its 2025 financial calendar, detailing key corporate events such as board meetings for financial statements approval and a half-year financial report. This move underscores Predict’s commitment to transparency and structured corporate governance, which may enhance stakeholder trust and reinforce its positioning in the healthcare industry.
More about Predict S.P.A. Class B
Established in 2008 in Bari, Predict S.p.A. is an innovative SME in the healthcare sector, focusing on in vivo diagnostics through ultrasound and radiological equipment distribution, as well as developing technologies in breath analysis and digital healthcare. The company is organized into four Strategic Business Units offering solutions in diagnostic imaging, breath analysis, and digital healthcare, partnering with leading Italian research institutes and hospitals.
YTD Price Performance: -7.46%
Average Trading Volume: 9,802
Learn more about PRE stock on TipRanks’ Stock Analysis page.